Alight to Participate in the Canaccord Genuity 44th Annual Growth Conference
Alight to Participate in the Canaccord Genuity 44th Annual Growth Conference
Alight (NYSE: ALIT or the “Company”), a leading cloud-based human capital technology and services provider, today announced that its President, Greg Goff, will present at the Canaccord Genuity 44th Annual Growth Conference in Boston on Tuesday, August 13, 2024 at 9 a.m. ET, available via live webcast and replay here.
About Alight Solutions
Alight is a leading cloud-based human capital technology and services provider for many of the world’s largest organizations. Through the administration of employee benefits, Alight powers confident health, wealth, leaves and wellbeing decisions for 35 million people and dependents. Our Alight Worklife ® platform empowers employers to gain a deeper understanding of their workforce and engage them throughout life’s most important moments with personalized benefits management and data-driven insights, leading to increased employee wellbeing, engagement and productivity. Learn how Alight unlocks growth for organizations of all sizes at alight.com.
Investor Contact:
Jeremy Cohen
Investor.Relations@alight.com
Media Contact:
Mariana Fischbach
Mariana.Fischbach@alight.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240809012745/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks